Derma Sciences (DSCI) Tops Q2 EPS by 6c

Derma Sciences (NASDAQ: DSCI) reported Q2 EPS of ($0.36), $0.06 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.66 million.

For earnings history and earnings-related data on Derma Sciences (DSCI) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh